Company Overview of Merrimack Pharmaceuticals, Inc.
Douglas A. Lauffenburger
Member of Scientific Advisory Board, Merrimack Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 7 Board Members in 7 organization across 8 different industries.|
See Board Relationships
One Kendall SquarePhone: 617-441-1000
Cambridge, Massachusetts 02139
Board Members MembershipsThere is no Board Members Memberships data available.
University of Minnesota
University of Illinois-Urbana-Champaign
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|John F. Thero||Chief Executive Officer, President and Director|
Amarin Corporation plc
|Adelene Q. Perkins||Chairman & CEO|
Infinity Pharmaceuticals, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals, Inc.
|Charles J. Link Jr., M.D.||Co-Founder, Chairman, CEO & Chief Scientific Officer|
NewLink Genetics Corporation
|Saeed Motahari||President, CEO & Director|
INSYS Therapeutics, Inc.
|--||Compensation as of Fiscal Year 2016.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.